Related Experiment Video
Updated: Jun 16, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Long-term oral baclofen treatment in a child with cerebral palsy: electroencephalographic changes and clinical
Marta De Rinaldis1, Luciana Losito, Leonarda Gennaro
1Neurorehabilitation Unit I, Developmental Neurology and Functional Rehabilitation, Scientific Institute IRCCS Eugenio Medea, La Nostra Famiglia, Ostuni, Italy.
Insights
Baclofen, used for cerebral palsy spasticity, may worsen epilepsy. A child experienced adverse effects and EEG changes, suggesting baclofen can potentiate seizures.
Area of Science:
- Neurology
- Pediatrics
- Pharmacology
Background:
- Baclofen is a common treatment for spasticity in pediatric cerebral palsy.
- The proconvulsant effects of baclofen remain debated despite its widespread use.
Observation:
- A 10-year-old female with cerebral palsy, epilepsy, and intellectual disability experienced adverse effects during baclofen therapy.
- Clinical symptoms included confusion, agitation, insomnia, hypotonia, and hyporeflexia.
- Electroencephalographic (EEG) monitoring revealed generalized burst of sharp waves, indicative of seizure potentiation.
Findings:
- The patient's EEG abnormalities emerged after a dosage increase of oral baclofen, within the therapeutic range.
- These findings suggest a direct link between baclofen escalation and seizure activity in this patient.
- The study explores potential mechanisms for baclofen's proconvulsant effect.
Implications:
- This case highlights the potential risk of baclofen-induced seizure potentiation in epileptic children with cerebral palsy.
- Clinicians should carefully monitor EEG and clinical status during baclofen treatment, especially with dosage adjustments.
- Further research is warranted to elucidate the precise mechanisms and identify at-risk populations.
Abstract:
Baclofen is widely used to control spasticity in children with cerebral palsy. Several publications described clinical adverse effects of baclofen oral treatment, but the effect of baclofen on seizure potentiation is still controversial. We describe a 10-year-old female patient with cerebral palsy, epilepsy, and mental retardation who developed clinical adverse effects (confusion, agitated state, insomnia, diffuse hypotonia, and hyporeflexia) and electroencephalographic (EEG) changes (quasiperiodic, generalized burst of sharp waves that take up >50% of standard EEG) during long-term oral baclofen treatment, after gradually increasing the dosage but still within the therapeutic dose. Our case showed clearly that the EEG changes in our patient, with a history of epilepsy in good control, have been induced by the baclofen increase, and we describe the possible mechanisms that could explain proconvulsive effect of baclofen.
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Alterations in Muscle Tone ll
